Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage

Podobne zapisy

• Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors
  od: Kim, Goo-Young, i wsp.
  Wydane: (2017)
• Hepatic glucose-6-phosphatase-α deficiency leads to metabolic reprogramming in glycogen storage disease type Ia
  od: Cho, Jun-Ho, i wsp.
  Wydane: (2018)
• Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia
  od: Lee, Young Mok, i wsp.
  Wydane: (2015)
• Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia
  od: Cho, Jun-Ho, i wsp.
  Wydane: (2018)
• Complete Normalization of Hepatic G6PC Deficiency in Murine Glycogen Storage Disease Type Ia Using Gene Therapy
  od: Yiu, Wai Han, i wsp.
  Wydane: (2010)